BRCA2 and neoplasm: Simultaneously, tumor organoids derived from the PDX model from the first patient with pleural TNBC metastasis with BRCA2 methylation were treated with two different PARP inhibitors (Olaparib and Rucaparib) in three different concentrations (25, 50 and 100 μM).